[Ip-health] Public comment on Sen. Wyden & Sen. Grassley Gilead-HepC report

Christina Chandra christina.chandra at amfar.org
Fri Jan 22 06:22:34 PST 2016


http://www.finance.senate.gov/imo/media/doc/012116%20Wyden%20Grassley%20Sovaldi%20Report%20Feedback%20FINAL4.pdf

Senators Ron Wyden and Chuck Grassley of the finance committee have asked health care professionals and patients to send in their thoughts on a recent Senate report about the steep price of Gilead's hepatitis C drug Sovaldi and its follow-on drug, Harvoni.



Christina Chandra
Allan Rosenfield Fellow

amfAR, The Foundation for AIDS Research
Public Policy Office
1150 17th Street NW, Suite 406
Washington, DC 20036
t. +1.914.372.9147
m. +1.404.219.1078 (USA)
e. christina.chandra at amfar.org<mailto:christina.chandra at amfar.org>




More information about the Ip-health mailing list